Anil K. Sood

The University of Texas MD Anderson Cancer Center

Also affiliated with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, BSCS Science Learning, The Ohio State University Wexner Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

25.0Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Papers

Driven by 76 papers — median percentile 97. Top paper: “An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics”.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Nature(2020)10.1038/s41586-020-1965-x

Top 5%

4.6DataRank

Top 5%668 citations

Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj +1240 more

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer

Cell Reports(2020)10.1016/j.celrep.2020.03.066

N/A

2.9DataRank · unranked

143 citations

Li Zhao, Christine Rojas, Nicholas W. Bateman, Hui Yao, Olivia D. Lara +41 more

Integrated genomic analyses of ovarian carcinoma

Nature(2011)10.1038/nature10166

N/A

1.3DataRank · unranked

8094 citations

Debra Bell, Andrew Berchuck, Michael J. Birrer, Jeremy Chien, D. W. Cramer +268 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial

Investigational New Drugs(2021)10.1007/s10637-020-01043-9

N/A

1.1DataRank · unranked

25 citations

Amir A. Jazaeri, Shannon N. Westin, Anil K. Sood, Lois M. Ramondetta, Mingxuan Xu +8 more

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer

Molecular Systems Biology(2014)10.1002/msb.20134892

N/A

0.875DataRank · unranked

340 citations

Tyler Moss, Lingegowda S Mangala, Juan Marini, Hongyun Zhao, Stephen Wahlig +14 more

Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)

Circulation(2024)10.1161/circulationaha.123.066604

N/A

0.773DataRank · unranked

24 citations

Brendan M. Everett, Alokananda Ghosh, Naji Younes, Heidi Krause‐Steinrauf, Joshua I. Barzilay +95 more

The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.06.498

N/A

0.598DataRank · unranked

53 citations

Charlotte C. Sun, Revathy B. Iyer, Alpa M. Nick, Nicole D. Fleming, Shannon N. Westin +5 more

Combined VEGFR and MAPK pathway inhibition in angiosarcoma

Scientific Reports(2021)10.1038/s41598-021-88703-9

N/A

0.533DataRank · unranked

34 citations

Yasmin A. Lyons, Jean Siedel, Robert Dood, Archana S. Nagaraja, Monika Haemmerle +8 more

PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101326

N/A

0.510DataRank · unranked

29 citations

Lacey E. Dobrolecki, Christina Sallas, Xudong Zhang, Travis Kerr, Deepa Bisht +19 more

Mitochondria in epithelial ovarian carcinoma exhibit abnormal phenotypes and blunted associations with biobehavioral factors

Scientific Reports(2021)10.1038/s41598-021-89934-6

N/A

0.442DataRank · unranked

18 citations

Marlon A. McGill, Marina K Triplett, Anisha Tyagi, Premal H. Thaker, Laila Dahmoush +9 more

Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes Care(2024)10.2337/dc23-2459

N/A

0.406DataRank · unranked

14 citations

Ionut Bebu, Heidi Krause‐Steinrauf, Claire J. Hoogendoorn, Gladys Crespo-Ramos, Caroline Presley +94 more

Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research

Carcinogenesis(2021)10.1093/carcin/bgab043

N/A

0.385DataRank · unranked

12 citations

Glauco Baiocchi, David D.L. Bowtell, Citadel J. Cabasag, Kathleen R. Cho, Renée T. Fortner +15 more

Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1–Mediated Cell Death in Uterine Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-1026

N/A

0.345DataRank · unranked

9 citations

Ying Wang, Anca Chelariu-Raicu, Elaine Stur, Yuan Liu, Sara Corvigno +8 more

Chronic difficulties are associated with poorer psychosocial functioning in the first year post‐diagnosis in epithelial ovarian cancer patients

Psycho-Oncology(2021)10.1002/pon.5682

N/A

0.312DataRank · unranked

7 citations

George M. Slavich, Andrew Schrepf, Lauren Z. Davis, Premal H. Thaker, Michael J. Goodheart +4 more

Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial

Med(2024)10.1016/j.medj.2024.07.022

N/A

0.299DataRank · unranked

4 citations

Minghao Dang, Sanghoon Lee, Bryan Fellman, Shannon N. Westin, Anil K. Sood +19 more

Special issues: The roles of special issues in scholarly communication in a changing publishing landscape

Learned Publishing(2024)10.1002/leap.1635

N/A

0.269DataRank · unranked

5 citations

Karen Smith‐McCune, Anil K. Sood, Robyn M. Gleasner

Does Emotional Distress Predict Worse Glycemic Control Over Time? Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes Care(2024)10.2337/dc23-0642

N/A

0.269DataRank · unranked

5 citations

Ionut Bebu, Heidi Krause‐Steinrauf, Claire J. Hoogendoorn, Gladys Crespo-Ramos, Caroline Presley +95 more

A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples

Genome Research(2024)10.1101/gr.278822.123

N/A

0.213DataRank · unranked

3 citations

Xiaoqian Liu, Xuesen Cheng, Yujie Jiang, Shuangxi Ji, Qingnan Liang +14 more

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

Communications Biology(2022)10.1038/s42003-022-03769-z

N/A

0.165DataRank · unranked

2 citations

Lars Feuerbach, Chen Hong, David Mas-Ponte, Randi Istrup Pedersen, PCAWG Drivers and Functional Interpretation Group +1255 more

Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.05.009

N/A

0DataRank · unranked

18 citations

Anil K. Sood, Graziela Zibetti Dal Molin, Shannon N. Westin, Larissa A. Meyer, Bryan Fellman +4 more

Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.004

N/A

0DataRank · unranked

8 citations

Siqing Fu, Apostolia M. Tsimberidou, Sarina A. Piha‐Paul, Fechukwu Akhmedzhanov, Bülent Yılmaz +16 more

Endothelial p130cas confers resistance to anti-angiogenesis therapy

Cell Reports(2022)10.1016/j.celrep.2022.110301

N/A

0DataRank · unranked

8 citations

Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M. Nick, Elaine Stur, Pahul Hanjra +10 more

Plasma and ovarian metabolomic responses to chronic stress in female mice

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.03.474852

N/A

0DataRank · unranked

3 citations

Tianyi Huang, Chirag J. Patel, Elizabeth M. Poole, Clary B. Clish, Guillermo N. Armaiz-Peña +9 more

Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101255

N/A

0DataRank · unranked

18 citations

Yang Li, Roger S. Smith, Bin Feng, Hui Dai, Limei Hu +9 more

Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors

American Journal of Obstetrics and Gynecology(2023)10.1016/j.ajog.2023.02.029

N/A

0DataRank · unranked

17 citations

Alejandra Flores Legarreta, Rhea Kamat, Katelyn F. Handley, Deanna Glassman, Jeffrey How +8 more

Navigating Barriers and Challenges to Achieving Critical Career Milestones Among Faculty Mentees

PubMed(2023)10.13016/m2spa5-qxsz

N/A

0DataRank · unranked

2 citations

J. Michael Martinez, Heidi Rishel Brakey, N Mickel, Anil K. Sood, B Soller

Mentoring Network Questionnaire Support Scales Reliable and Valid with University Faculty

PubMed(2023)10.13016/m2xskr-nhgi

N/A

0DataRank · unranked

2 citations

Brian Soller, Orrin Myers, Xin Shore, N Mickel, Nora Domínguez +4 more

Gender Differences in Self-reported Faculty Developmental Networks

PubMed(2023)10.13016/m203bl-z68l

N/A

0DataRank · unranked

1 citations

Brian Soller, N Mickel, Brandt Wiskur, Dadonim Vila Morales, Nora Domínguez +5 more

Data from The Previously Undescribed ZKSCAN3 (ZNF306) Is a Novel “Driver” of Colorectal Cancer Progression

(2023)10.1158/0008-5472.c.6497645

N/A

0DataRank · unranked

0 citations

Stanley R. Hamilton, Anil K. Sood, Toshio Kuwai, Lee M. Ellis, Ángela Sanguino +3 more

Data from Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles

(2023)10.1158/1078-0432.c.6519131.v1

N/A

0DataRank · unranked

0 citations

Lingegowda S. Mangala, Jeong Won Lee, Mian M.K. Shahzad, Hye Sun Kim, De-yu Shen +10 more

Supplementary Figures 1-8 from Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles

Figshare(2023)10.1158/0008-5472.22387437.v1

N/A

0DataRank · unranked

0 citations

Lingegowda S. Mangala, Pablo E. Vivas‐Mejía, René Nieves-Alicea, Aman P. Mann, Edna Mora +16 more

Data from Therapeutic Targeting of ATP7B in Ovarian Carcinoma

(2023)10.1158/1078-0432.c.6517644

N/A

0DataRank · unranked

0 citations

Vesna Zuzel, Rosemarie Schmandt, Erik S LeShane, Jyotsna B. Halder, Guillermo N. Armaiz-Peña +16 more

Data from Therapeutic Targeting of ATP7B in Ovarian Carcinoma

(2023)10.1158/1078-0432.c.6517644.v1

N/A

0DataRank · unranked

0 citations

Vesna Zuzel, Rosemarie Schmandt, Erik S LeShane, Jyotsna B. Halder, Guillermo N. Armaiz-Peña +16 more

Data from c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer

(2023)10.1158/1078-0432.c.6518626.v1

N/A

0DataRank · unranked

0 citations

Juliana M. Benito, Ariel Fernández, Hee-Dong Han, Lingegowda S. Mangala, Cristian Rodriguez-Aguayo +14 more

Data from c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer

(2023)10.1158/1078-0432.c.6518626

N/A

0DataRank · unranked

0 citations

Juliana M. Benito, Ariel Fernández, Hee-Dong Han, Lingegowda S. Mangala, Cristian Rodriguez-Aguayo +14 more

Ovarian cancer metastasis: Looking beyond the surface

Cancer Cell(2024)10.1016/j.ccell.2024.08.016

N/A

0DataRank · unranked

55 citations

Sisy Chen, Sara Corvigno, Jinsong Liu, Anil K. Sood, Emine Bayraktar

EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer

International Journal of Molecular Sciences(2024)10.3390/ijms25021278

N/A

0DataRank · unranked

8 citations

Santosh K. Dasari, Sujanitha Umamaheswaran, Lingegowda S. Mangala, Emine Bayraktar, Cristian Rodriguez‐Aguayo +17 more

Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy

Diabetes Care(2024)10.2337/dc23-1059

N/A

0DataRank · unranked

7 citations

Naji Younes, Nicole M. Butera, Ashok Balasubramanyam, Richard M. Bergenstal, Joshua I. Barzilay +95 more

Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes Care(2024)10.2337/dc23-1332

N/A

0DataRank · unranked

6 citations

Mark Tripputi, Heidi Krause‐Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry B. Burch +95 more

Mortality in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes Care(2024)10.2337/dc23-1356

N/A

0DataRank · unranked

5 citations

John B. Buse, Naji Younes, Heidi Krause‐Steinrauf, Adline Ghazi, Melissa Lee +95 more

Quality of life and survivorship in patients with low-grade ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.08.010

N/A

0DataRank · unranked

1 citations

Rachel Telles, Michael J. Goodheart, Laila Dahmoush, Ian S. Hagemann, Frank J. Penedo +6 more

Feasibility of using the handheld MasSpec pen technology for intraoperative identification of ovarian cancer during tumor reductive surgery.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.5573

N/A

0DataRank · unranked

1 citations

Charles A. Wolfe, Michael F. Keating, Marta Sans, Kelly M. Rangel, Calvin Sunny +10 more

Association of Forced Vital Capacity with the Developmental Gene NCOR2

Tampere University Institutional Repository (Tampere University)(2024)10.17615/agfx-qc43

N/A

0DataRank · unranked

0 citations

Lies Lahousse, Henry Völzke, K. De Jong, Thor Aspelund, G. Eiríksdóttir +95 more

Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis

Cell Insight(2025)10.1016/j.cellin.2025.100238

N/A

0DataRank · unranked

4 citations

Anil K. Sood, Shang-Jui Wang, Peng Wang, Ahmed Fadiel, Anil V. Parwani +6 more

EphA2 siRNA in DOPC nanoliposomes (EPHARNA): A phase I clinical trial in patients with solid tumors.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.3086

N/A

0DataRank · unranked

0 citations

Aung Naing, Gabriel Lopez‐Berestein, Cristian Rodríguez-Aguayo, Hassan Ahmed Momin, Anupama Madhyannapu +11 more

Plasma and ovarian metabolomic responses to chronic stress in female mice

Metabolomics(2025)10.1007/s11306-025-02287-3

N/A

0DataRank · unranked

0 citations

Tianyi Huang, Chirag J. Patel, Elizabeth M. Poole, Clary B. Clish, Guillermo N. Armaiz-Peña +10 more

Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterations

ESMO Open(2025)10.1016/j.esmoop.2025.105895

N/A

0DataRank · unranked

0 citations

Chieh Tseng, Hai T. Tran, Siqing Fu, Ecaterina E. Dumbrava, Timothy A. Yap +8 more

Rural-urban disparities in psychosocial functioning in epithelial ovarian cancer patients

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.024

N/A

0DataRank · unranked

2 citations

M. Bridget Zimmerman, Premal H. Thaker, George M. Slavich, Edgardo Ramírez, Sharaf Zia +5 more

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower

Nature Communications(2022)10.1038/s41467-022-32343-8

N/A

0DataRank · unranked

0 citations

PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Pratiti Bandopadhayay, Rameen Beroukhim +1242 more

Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0030

N/A

0DataRank · unranked

16 citations

Shaolin Ma, Anca Chelariu-Raicu, Carola Leuschner, Hector W. Alila, Sanghoon Lee +3 more

Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions

Scientific Reports(2020)10.1038/s41598-020-57477-x

N/A

0DataRank · unranked

14 citations

Yunfei Wen, Jun Zhao, Dengke Yin, Lingyun Xu, Anca Chelariu-Raicu +8 more

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer

Oncotarget(2020)10.18632/oncotarget.27667

N/A

0DataRank · unranked

10 citations

Emine Bayraktar, Paola Amero, Shaolin Ma, Cristina Ivan, Wei Hu +9 more

Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer

International Journal of Gynecological Cancer(2020)10.1136/ijgc-2020-001718

N/A

0DataRank · unranked

8 citations

Shannon N. Westin, Larissa A. Meyer, Aaron Shafer, Jose Alejandro Rauh‐Hain, Michaela Onstad +12 more

Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102169

N/A

0DataRank · unranked

35 citations

Wanqin Wang, Min Zhou, Qian Huang, Xiaoxia Wen, Jun Zhao +11 more

miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

UNC Libraries(2020)10.17615/zrq5-5095

N/A

0DataRank · unranked

3 citations

Denise Brooks, Preethi H. Gunaratne, Payal Sipahimalani, Clara Chan, Jacquie Schein +23 more

Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer

International Journal of Gynecological Cancer(2020)10.1136/ijgc-2020-001597

N/A

0DataRank · unranked

1 citations

Rebecca A. Previs, Bryan Fellman, Tarrik M. Zaid, Marilyn Huang, Alaina J. Brown +10 more

FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal

UNC Libraries(2020)10.17615/m9fn-7d51

N/A

0DataRank · unranked

1 citations

Hee Dong Han, Vahid Afshar‐Kharghan, Anil K. Sood, Heather J. Dalton, Min Soon Cho +19 more

Integrated genomic analyses of ovarian carcinoma

UNC Libraries(2020)10.17615/fke4-z664

Top 100%

0DataRank

Top 100%0 citations

Pat Glenn, Michael J. Birrer, Nicholas J. Petrelli, Beth Y. Karlan, Mei Huang +27 more

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

UNC Libraries(2020)10.17615/atet-cc90

N/A

0DataRank · unranked

0 citations

Laurence J.N. Cooper, Rouba Ali‐Fehmi, Monika Haemmerle, Elizabeth Pham, Keith Baggerly +32 more

Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression

UNC Libraries(2020)10.17615/egeq-gj87

N/A

0DataRank · unranked

0 citations

Anil K. Sood, Guillermo N. Armaiz-Peña, Justyna Filant, Elizabeth A. Koch, Michael A. McGuire +24 more

Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells

UNC Libraries(2020)10.17615/etcd-cg63

N/A

0DataRank · unranked

0 citations

Gina M. Nelkin, Dominic Fan, Anil K. Sood, Michael D. Schaller, Nicholas B. Jennings +5 more

The life cycle of polyploid giant cancer cells and dormancy in cancer: Opportunities for novel therapeutic interventions

Seminars in Cancer Biology(2021)10.1016/j.semcancer.2021.10.005

N/A

0DataRank · unranked

60 citations

Na Niu, Xiaoran Li, Xudong Zhang, Anil K. Sood, Jinsong Liu

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer

Cancers(2021)10.3390/cancers13040626

N/A

0DataRank · unranked

56 citations

Puja Iyer, Shinya Matsuzaki, Koji Matsuo, Anil K. Sood, Nicole D. Fleming +1 more

Rural residence is related to shorter survival in epithelial ovarian cancer patients

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.07.035

N/A

0DataRank · unranked

29 citations

Edgardo Ramírez, Andrew Schrepf, Mark C. Valentine, Mary E. Charlton, M. Bridget Zimmerman +5 more

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway

International Journal of Molecular Sciences(2021)10.3390/ijms22041882

N/A

0DataRank · unranked

28 citations

Emine Bayraktar, Paola Amero, Salama A. Salama, Abdel‐Aziz H. Abdel‐Aziz, Raed S. Ismail +6 more

Antihypertensive medication use and ovarian cancer survival

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.09.009

N/A

0DataRank · unranked

20 citations

Mary K. Townsend, Robert Dood, Anil K. Sood, Shelley S. Tworoger, Tianyi Huang

EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5505

N/A

0DataRank · unranked

83 citations

Robert L. Coleman, Bryan Fellman, Ying Yuan, Anil K. Sood, Pamela T. Soliman +15 more

Correlation of HRD status with clinical and survival outcomes in patients with advanced-stage ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5568

N/A

0DataRank · unranked

5 citations

Anil K. Sood, Shannon N. Westin, Bryan Fellman, Jenna Unke, Kelly M. Rangel +3 more

Selinexor in combination with weekly paclitaxel in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multiarm phase 1b study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5565

N/A

0DataRank · unranked

0 citations

Siqing Fu, Apostolia M. Tsimberidou, Sarina A. Piha‐Paul, Fechukwu Akhmedzhanov, Bülent Yılmaz +15 more

Platelets Increase the Expression of PD-L1 in Ovarian Cancer

Cancers(2022)10.3390/cancers14102498

N/A

0DataRank · unranked

29 citations

Hani Lee, Ricardo J. Gonzalez, Dan Li, Tomoyuki Sasano, Wendolyn Carlos‐Alcalde +5 more

Broad-acting therapeutic effects of miR-29b-chitosan on hypertension and diabetic complications

Molecular Therapy(2022)10.1016/j.ymthe.2022.08.007

N/A

0DataRank · unranked

21 citations

Peng Han, Lingegowda S. Mangala, Gabriel Lopez‐Berestein, Anil K. Sood, Jing Liu +5 more

Anil K. Sood

Indexed papers

Top data-sharing exemplar

Papers